Our Services
Medical Information
Helpful Resources
Published on: 1/30/2026
Farxiga 10 mg can raise the chance of UTIs and vaginal yeast infections, with yeast infections more common, because it increases sugar in urine. Lower your risk with steady hydration and not holding urine, gentle fragrance free hygiene, keeping the area dry with breathable cotton underwear, tight glucose control, and cautious antibiotic use; know early symptoms, when to seek urgent care, and do not stop Farxiga without medical advice. There are several factors to consider and options if infections recur; see below to understand more.
Farxiga (dapagliflozin) is a widely prescribed medication for type 2 diabetes, heart failure, and chronic kidney disease. It works by helping the kidneys remove extra sugar through the urine. For many women, Farxiga offers meaningful health benefits. However, because more sugar leaves the body in urine, it can raise the risk of urinary tract infections (UTIs) and vaginal yeast infections.
This guide explains why these infections can happen, what increases your risk, and practical, evidence-based steps you can take to lower that risk—without fear-based messaging or unrealistic promises.
Farxiga belongs to a drug class called SGLT2 inhibitors. These medications lower blood sugar by preventing the kidneys from reabsorbing glucose. Instead, glucose is excreted in urine.
For women, this can create an environment where bacteria and yeast grow more easily.
Clinical trials and real-world data consistently show that genital yeast infections are more common than UTIs in women taking Farxiga. Most infections are mild to moderate and treatable, but prevention matters.
Not every woman on Farxiga will get a UTI or yeast infection. Your risk may be higher if you:
Knowing your personal risk helps you take targeted prevention steps.
Drinking enough fluids helps flush bacteria out of the urinary tract.
Because Farxiga can increase urination, dehydration can sneak up on you. You may want to consider doing a free, online symptom check for Dehydration if you notice dizziness, dry mouth, or fatigue.
Holding urine allows bacteria more time to grow.
These small habits can significantly lower UTI risk.
Cleanliness matters, but over-cleaning can backfire.
These products can disrupt healthy bacteria and irritate tissue.
Yeast thrives in warm, moist environments.
At night, some women find it helpful to wear looser sleepwear or go without underwear.
Higher blood sugar means more sugar in urine.
Better glucose control is one of the most effective ways to reduce yeast infection risk.
Antibiotics can kill helpful bacteria that keep yeast in check.
Catching infections early often leads to easier treatment and less discomfort.
If symptoms are mild, treatment is usually straightforward. Do not ignore symptoms hoping they will go away.
If UTIs or yeast infections keep coming back while on Farxiga, it does not automatically mean you must stop the medication. Options your doctor may discuss include:
Never stop Farxiga on your own without medical advice, especially if you are taking it for heart or kidney protection.
While most infections are mild, some symptoms need prompt medical attention. Speak to a doctor immediately if you experience:
These could signal a more serious infection that requires urgent treatment.
Farxiga has been shown in large clinical studies to:
For many women, these benefits outweigh the infection risk—especially when preventive steps are taken. The goal is not to minimize the risks, but to manage them proactively.
If you are taking Farxiga and notice new or worsening symptoms, speak to a doctor—especially about anything that feels serious or could be life threatening. Personalized medical advice is essential, and your care team can help you balance the benefits of Farxiga with smart strategies to protect your comfort and health.
(References)
* Cai Z, Chen M, Liu Y, Li C, He J, Ma Z. Managing Urogenital Mycotic Infections in Patients Treated with SGLT2 Inhibitors: A Narrative Review. Front Endocrinol (Lausanne). 2022 Mar 3;13:825595. doi: 10.3389/fendo.2022.825595. eCollection 2022. PMID: 35308960; PMCID: PMC8929944.
* Mendes D, Alves C, da Silva-Maia P, Ruas V, Roque F, Figueiras A, Paredes S. SGLT2 inhibitors and genital infections: an updated narrative review. Expert Opin Drug Saf. 2023 Feb;22(2):167-179. doi: 10.1080/14740338.2023.2173199. Epub 2023 Feb 8. PMID: 36749117.
* Raz I, Nyirjesy P, Rosenberg E, Liu M, Hirshberg B, Johnson JR, Ptaszynska A. A practical guide to the prevention and management of urogenital infections in patients taking SGLT2 inhibitors. Diabetologia. 2019 Jul;62(7):1131-1141. doi: 10.1007/s00125-019-4860-9. Epub 2019 Apr 12. PMID: 30976822.
* Nyirjesy P, Draghici A. Urogenital Infections Associated With SGLT2 Inhibitors. Curr Diab Rep. 2017 Jul;17(7):49. doi: 10.1007/s11892-017-0873-1. Review. PMID: 28620857.
* Yang Z, Zhang Y, Wen J, Yan X. Risk of Genital and Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Ther. 2018 Jun;9(3):1021-1031. doi: 10.1007/s13300-018-0402-2. Epub 2018 Mar 15. PMID: 29546685; PMCID: PMC6014798.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.